Tag | Content |
---|
EnhancerAtlas ID | HS127-18032 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr2:182168510-182170310 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF5 | MA0599.1 | chr2:182168941-182168951 | GCCCCGCCCC | + | 6.02 | NFIL3 | MA0025.1 | chr2:182169132-182169143 | TTATGTAACAT | + | 6.32 | PHOX2A | MA0713.1 | chr2:182168571-182168582 | TAATTAAATTA | - | 6.62 | PROP1 | MA0715.1 | chr2:182168571-182168582 | TAATTAAATTA | + | 6.32 | PROP1 | MA0715.1 | chr2:182168571-182168582 | TAATTAAATTA | - | 6.62 | Phox2b | MA0681.1 | chr2:182168571-182168582 | TAATTAAATTA | - | 6.62 | SPI1 | MA0080.4 | chr2:182168778-182168792 | CAAATGAGGAAGTT | + | 6.2 |
|
| Number of super-enhancer constituents: 16 | ID | Coordinate | Tissue/cell |
SE_10328 | chr2:182168501-182175302 | CD19_Primary | SE_11276 | chr2:182168380-182180787 | CD20 | SE_12124 | chr2:182168576-182175378 | CD3 | SE_13148 | chr2:182168713-182172653 | CD34_Primary_RO01480 | SE_13870 | chr2:182168554-182175255 | CD34_Primary_RO01536 | SE_14299 | chr2:182168531-182175400 | CD34_Primary_RO01549 | SE_22764 | chr2:182168390-182179973 | CD8_primiary | SE_25641 | chr2:182168497-182175170 | DND41 | SE_31286 | chr2:182168416-182175187 | Fetal_Thymus | SE_39630 | chr2:182168232-182172575 | Jurkat | SE_43571 | chr2:182168254-182180421 | MM1S | SE_58761 | chr2:182168231-182179528 | Ly1 | SE_60876 | chr2:182168489-182178681 | DHL6 | SE_61469 | chr2:182165015-182180772 | Toledo | SE_62509 | chr2:182165210-182180093 | Tonsil | SE_66350 | chr2:182168232-182172575 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I181303 | chr2 | 182168600 | 182180186 |
|
Enhancer Sequence | TATTATATTG ATATATTTAT TTAAATTTAT ATTTAAAAAC TGGGTTATCT GACTTATTGC 60 CTAATTAAAT TAAGATTTCA GCAAAAATCA GAGATAATTT TTTGAATATC TTGGCGATAT 120 ATGTGGGGGG ATGTACTACT TTTATTTTTA AAACTCTGTG AAAGTACCTC CTGCTGACCA 180 GGCAGAATTC TAAATAATTT ACAAATATTA ATTCAGATAA TCATACTGAC AACTCTATTC 240 AGGGTCTACT AGTGGGATGC CCAGTTTGCA AATGAGGAAG TTAAGTAGCT TATATTCAAG 300 GTCAGACCAC AAAGTGGCAG AATAGGATTC AAAATGACGC CAGAGTCTAT GTTACTGTTT 360 GAAAAGAATA TTCAGCCATA TCTGAGCAGG TTTTATTTAT TAATTAGAGG TCAAAGCCAT 420 GGAAAAGATT AGCCCCGCCC CAAGTCTTGG TAGCTTAGTG GCAGGTCATC TAGGGCCCTG 480 GAGTCTCCCT TTCAGCTGTC CCTCTGTGTG ATATTTTGGA GCTGGGGTCA TGCCTTACCT 540 GCCTCCTCCT GGGGCCCTAT CTGCTGAATA CTATGACAGC GGGCAATAAA GGGAAGTTAG 600 CATCAAAAGG CAGCCCTTCT CTTTATGTAA CATAGAAATG ACCCTTTCTT TATTTTTGAC 660 TGACCACAGC TACCTTAGTA TTAGGTTAGC CTTGGTTACA GACTGGGTTT TGGTTTTGGT 720 GATAAGTATG ACTTTTGTAA TTCTTTGAAA CCTCTGCAAT GCCTCTCAAT TGCCCTATGA 780 ACAATGTAAA TTTGGGAGTA TAACTAAATG CAGATCTTCA CAGATTGGAG TTTGAACTTG 840 CCTCTTCAGC AAGGGACTGG GACGGCTCTT TATTACTACG GGATGTTTTT CTCATCTTCT 900 AGAGCTTAAG TAAAAAAAAT CTAGTTTCTC TTTGGGTAGT GAGGATGAAC TGTAGATACT 960 TCTTCACAAG CTCAAGGAAA ACACATTAGA CTTTCCTAGT CATAAATGAA GTCTCATTAT 1020 GCTACAGGAG AAAACAGAGT TTTAAAAGTA ACTATACTAT CTAACTCTTT TTTAGTTTTA 1080 TCACTGAATC TTGAATAATA GAACATAAGC AGTTGTTCGG ATTTAAATTA TTCTTCCCTC 1140 TTGAATTACT GTTCAACACC CTAAGATCAC CATACGTATT ATTTCAGAAA ATGAAGAGCC 1200 TTAAAAATTG TCTCAGAAAT TTTATTTCCT TATATTATAA TTGAAATTTG GTAACTTCCC 1260 TCAAGATTAA TAGAAAAGTT GTTCTAAAAT CAACAAAACA TGTTCACTTA ATTTTTTTCC 1320 CCCACACTGT GGGTAGGAGC TAATATTTAC TGAGGGTCCA GCACATGCCA GGCATTTTAC 1380 TTTACTTAAG CCCATGCTCA GTATATGTGG TGAATATTGC TTCTTTTTAT TTTATTGGCA 1440 AAGAAATGAA ATCTCAGAGG CATTAGACAA ATTACCCAAG CCTACCCAGG CCCTAAGAGG 1500 AGTCCAAACT GGGGTTATTC TGGCCTAAAA ATAATGTGCT TTGCCCATCA CAATACCACA 1560 AACTTTTTAA AATCTTGATC ATTTCCACAT TTCAATTAAT CATCAGCATC AATGACGCAC 1620 TTTAAAAGAG GAGGAGTATT TTTTAAAGAG AGACCTATTT ACTCTTTTGG TCGGAGGCGT 1680 AGAAATTATG CTAAATACTA TGCATAACTT ACTTTGGCAA GTGCAATGGT TAAAACTAAG 1740 TACTAGTGTG CTTAAATACT TCCTTATTCA ACAATTATAA TGCAGATTAA AGCCCAAGTG 1800
|